ERBB2 and neoplasm: Specifically, this correlation was observed in patients with BRCA and its subtypes (basal, HER2, and luminal), where reduced KLRB1 expression levels were linked to tumor purity, B cells, CD8+ T cells, CD4+ T cells, neutrophils, and dendritic cells (Table 6).